Pfizer, Thermo Fisher Scientific And More: CNBC’s ‘Final Trades’
Benzinga · 15 de oct de 2026
CNBC Final Trades: Weiss picked 10-year Treasuries, Thomas chose XAR, Firestone favored TMO, and Terranova selected PFE.
CEDEAR TMO
Thermo Fisher Scientific Inc.
Sí, existe CEDEAR de TMO en Argentina. Operás bajo el ticker TMO en BYMA, con ratio 22:1 respecto a la acción en NYSE.
Empresa subyacente
HealthcareDiagnostics & Research
Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services internationally. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Biopharma Services. The Life Sciences Solutions segment includes reagents, instruments, and consumables for biological and medical research; discovery and production of drugs and vaccines; and diagnosis of infections and diseases. Its Analytical Instruments segment provides instruments, consumables, software, and services for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The Specialty Diagnostics segment offers clinical diagnostics products, such as liquid ready-to-use and lyophilized immunodiagnostic reagent kits, calibrators, controls, protein detection assays, and instruments; immunodiagnostic offerings comprising developing, manufacturing, and marketing of complete blood-test systems for the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases; microbiology offerings, such as dehydrated and prepared culture media, collection and transport systems, instrumentation and consumables to detect pathogens in blood, diagnostic and rapid direct specimen tests, quality-control products, and associated products; transplant diagnostics products, including human leukocyte antigen typing and testing for the organ transplant market; and healthcare market channel offerings. Its Laboratory Products and Biopharma Services segment provides laboratory products, research and safety market channel, and pharma services and clinical research. Thermo Fisher Scientific Inc. was founded in 1956 and is headquartered in Waltham, Massachusetts.
- País
- United States
- Empleados
- 125.000
- Sitio web
- thermofisher.com
Precio histórico
No hay suficientes datos históricos para mostrar el gráfico de TMO.
Cotización y datos
NYSERatio 22:1 · Subyacente TMO
CEDEAR (ARS)
Precio
$ 50.875
Var. %
+2,69%
Volumen operado
146
Subyacente (USD)
Precio TMO
US$ 693,01
Teórico (precio / ratio)
TMO ÷ 22
US$ 31,50
Dólar MEP (TMOD)
Preguntas frecuentes
¿Existe CEDEAR de TMO en Argentina?
Sí, existe el CEDEAR de TMO (Thermo Fisher Scientific Inc.) en la Bolsa de Comercio de Buenos Aires (BYMA). Su ticker local es TMO.
¿Cuál es el ticker del CEDEAR de Thermo Fisher Scientific Inc.?
El ticker del CEDEAR de Thermo Fisher Scientific Inc. en Argentina es TMO. La acción subyacente cotiza en NYSE con el símbolo TMO.
¿Cuál es el ratio del CEDEAR TMO?
El CEDEAR TMO tiene un ratio de 22:1. Eso significa que 22 CEDEARs equivalen a 1 acción de TMO.
¿Cuánto vale el CEDEAR TMO hoy?
El CEDEAR TMO cotiza hoy a $ 50.875 en pesos argentinos, con una variación diaria de +2,69%.
¿Cuánto vale la acción TMO en dólares?
Noticias
How To Invest In AI Drug Discovery
SeekingAlpha · 15 de oct de 2026
While AI can design prospective drug molecules in seconds, validating whether they work still depends on slow physical wet-lab testing and custom testing tools.
Quantum BioPharma’s Phase 2 Shows Where Biotech Value Actually Gets Built
Yahoo · 14 de oct de 2026
Biotech stocks trade on FDA trial phases. Phase 2 data often builds value, cash runway limits dilution, and Quantum BioPharma just began a phase 2 MS trial.